Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Wayland Group Corp MRRCF

Healthcare Biotechnology Drug Manufacturers - Specialty & Generic Cannabis
Wayland Group Corp, formerly Maricann Group Inc produces and sells medical marijuana. It is currently engaged in cultivation, extraction, analytics and production facilities to elevate offerings and prepare for growth into the adult-use cannabis market in Canada.


GREY:MRRCF - Post by User

Wayland Group Corp
Bullboard Posts
User Avatar Image
(0)
•••
Comment by CosmoKrameon May 22, 2018 9:41pm
132 Views
Post# 28067017

RE:RE:RE:RE:So happy Mari is not diluting shareholders look at AcB Cbw

RE:RE:RE:RE:So happy Mari is not diluting shareholders look at AcB CbwI am unsure they will have issues raising capital.  Lets not forget the automation equipment from rockwell was financed by rockwell themselves. They have also raised some capital in the EU via their german subsidiary.  If they absolutely needed capital, I believe they could get it.  At this point I think MARICANN is best off operating lean and not diluting shareholders.  2019 will be a profitable year says Ben.  Earning by end of this month will provide clarity on that goal.  MARI is in a unique position compared to its peers.  Risk Vs Reward needs to meet your appetite tho. 
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities